Sulfobutyl beta cyclodextrin sodium cas non 182410-00-0 factum in Sina de deli. Nostra Factory est celebre sulfobutyl beta cyclodextrin sodium cas non 182410-00-0 Manufacturers et Sina. Nos providebit liberum sample. Nostrum products sunt in stirpe. Welcome emere nostra mole products.
Sumus specialized in productio Tetadex sulfobutyl Aether sodium. Est ducit manufacturer of pharmaceutical excipients in Sinis. Nomen: Sulfobutyl Athadex DMF NOBUS NOVE: (XXXIV) DCCLXXIII / PROPOD Gradus / USP nomen: Iniectio PROPODIUM PROPODEX SULFOBUBUTYL
Sulfobutyl beta cyclodextrin sodium cas non 182410-00-0 est novum genus anionic altum solutum cyclodextrin derivationes in Sina Deli, quod potest esse ut solubilizer, madentis agente, chelaing agente masking agente.
Sulfobutyl beta cyclodextrin sodium cas non 182410-00-0 est in iniectio, oris, nasi et oculus medicina. Hoc est specialis affinitate et inclusione ad NITROGENIUM medicinae. Augmentum medicamento scriptor stabilitatem, solubility, salus (includit medicamento moleculis ad formare non-covalent). Redigendum renum toxicity, otium medicamento hemolysis. Sulfobutyl Ather Beta CyclodExtrin sodium etiam potest control medicamento release rate, operiet mala odor.
Sulfobutyl beta cyclodextrin sodium cas non 182410-00-0
[Molecular formula]: c42h70-no35 · (c4h8so3na) n
[Grade]: iniectio gradu
[Effectus Latin]: USP / EP / Enterprise Latin
[Specification]: 500g / peram; 1KG / peram; 10Kg / peram; 10Kg / tympanum.
[Application regio]: medicina
|
Description et solubility / See Details in USP Monograph |
White to off-white,amorphous powder.Freely soluble in water;sparingly soluble in methanol;practically insoluble in ethanol,in n-hexane,in 1-butanol,in acetonitrile,in 2-propanol,and in ethylacetate |
|
Idem a / ir; USP <197k> |
Complies SBECD Reference |
|
Identification B / (Asia Methodo) HPLC; USP |
TR De Maior apicem obsequitur SBECD reference |
|
Idem c / CE; USP |
Nihil occurrit in test enim mediocris gradus substitutionis. |
|
D / USP |
Positivum test ad sodium |
|
Asay / Hplc, USP |
95.0% -105.0% in anhydrous |
|
Limit de Beta Cyclodextrin (Antiqua) / IC; USP |
NMT 0.1% |
|
Low of 1,4-butane Sultone / GC; USP |
NMT 0.5PPM |
|
Low of sodium chloride / IC; USP |
NMT 0.2% |
|
IV-I-Sulfonic Acidum-hydroxybutane terminum / IC; USP |
NMT 0.09% |
|
Low of bis (IV-sulfobutyl) aether disod / IC; USP |
NMT 0.05% |
|
Bacterial Endotoxins test / USP |
≤10eu / g |
|
Microbial enumeration probat / USP |
Tamc≤100cfu / G Tymc≤50 CFU / G |
|
Probat pro certa microorganisms / USP |
Absentia ex Escherichia coli / 1g |
|
Claritas solution (XXX%, w / v) / Visual; vide singula in USP Monograph |
Solutio patet, et essentialiter a particulis aliena materia. |
|
Mediocris gradus substitutionis [DS] / CE, USP |
6.2-6.9 |
In potentiale Beta-CyclodExtrins sicut pharmaceutical auxilium constitutum per aliquot decennia investigationis. Autem, quidam beta-cyclodextrins sunt relatum esse toxicus causing Delterious effectus in longa terminus usus. In recens praeteritum, sulfobutyl aethere beta cyclodextrin sodium, a mutatio beta-cyclodextrin habet captum interest ut comparative tutius et solubility et bioavailabt in Biopharmaceutical System et Bioavailabt Power. Sulfobutyl Ather Beta CyclodExtrin sodium est demonstratum immense potentiale in addressing solubility et stabilitatem exitibus consociata cum formula medicinae.
Of Factory erat statutum in MCMXCIX et habet focused in productione cyclodextrin pro magis quam XX annis. Et Sulfobutyl Ather Beta CyclodExtrin sodium produci a factory habet princeps cedat, humilis pretium et praestatur qualitas, we receperint vos ut inquire de Product Details.
